adenoviru
discov
remov
adenoid
tonsil
children
yield
transmiss
cytopath
agent
cultur
sever
week
serial
pass
epitheli
cell
produc
enlarg
round
cell
strand
connect
day
infect
adenoviru
also
isol
adenoid
tissu
pulmonari
secret
adult
respiratori
tract
symptom
militari
recruit
eye
shipyard
worker
conjunct
adenoviru
caus
approxim
upper
respiratori
infect
children
younger
year
pneumonia
childhood
lung
play
critic
role
suppli
bodi
cell
oxygen
remov
wast
product
lung
continu
expos
inhal
gase
particul
airborn
pathogen
result
daili
inhal
ten
thousand
liter
air
despit
exposur
lower
airway
abl
remain
steril
due
remark
effici
host
defens
system
pulmonari
mucos
surfac
surfac
consist
epitheli
cell
cell
cell
dendrit
cell
abl
respond
microbi
exposur
activ
humor
cellmedi
immun
respons
product
inflammatori
mediat
ie
cytokin
chemokin
antimicrobi
peptid
breakdown
host
defens
especi
lung
expos
highli
virul
organ
overwhelm
inoculum
result
infect
respiratori
tract
infect
lung
typic
occur
aspir
upper
airway
resid
flora
inhal
aerosol
materi
metastat
seed
lung
infecti
agent
system
chapter
describ
common
viral
caus
respiratori
tract
infect
pulmonari
mucos
immunolog
respons
common
respiratori
virus
mucos
immunolog
virolog
capsomer
arrang
structur
side
vertic
compris
hexon
neutral
antibodi
direct
major
typespecif
neutral
epitop
fiber
hexon
adenoviru
synthes
sever
protein
includ
famili
transform
protein
region
three
protein
region
respons
replic
viral
genom
protein
region
control
host
immun
cytokin
respons
infect
protein
region
facilit
viral
messeng
rna
mrna
transcript
peopl
experienc
primari
infect
adenoviru
first
year
life
infect
individu
adenoviru
may
asymptomat
infect
may
result
respiratori
ill
pneumonia
croup
bronchiti
acut
respiratori
diseas
caus
adenoviru
describ
condit
crowd
stress
among
militari
recruit
world
war
ii
season
pattern
adenoviru
commonli
occur
late
winter
spring
earli
summer
adenoviru
caus
nonrespiratori
tract
infect
gastroenter
conjunct
cystiti
rash
incub
period
adenoviru
day
common
symptom
associ
adenoviru
infect
cough
fever
sore
throat
rhinorrhea
symptom
typic
last
day
classif
system
adenoviru
serotyp
clinic
signific
associ
serotyp
age
clinic
spectrum
diseas
infant
serotyp
caus
fulmin
bronchiol
pneumonia
children
adenoviru
serotyp
associ
upper
respiratori
diseas
young
adult
particularli
militari
recruit
serotyp
associ
acut
respiratori
diseas
tracheobronch
pneumonia
immunocompromis
patient
serotyp
associ
pneumonia
dissemin
transmiss
adenoviru
occur
direct
contact
fecalor
transmiss
occasion
waterborn
transmiss
adenovirus
abl
surviv
outsid
bodi
prolong
period
time
due
abil
remain
stabl
chemic
physic
agent
advers
ph
condit
adenoviru
capabl
lytic
infect
latent
chronic
infect
oncogen
adenoviru
uniqu
characterist
possess
high
oncogen
potenti
first
human
viru
demonstr
oncogen
potenti
rodent
modifi
adenoviru
use
vector
insert
genet
materi
differ
type
cell
gene
therapi
immun
pathogen
sinc
initi
descript
adenoviru
least
serotyp
adenoviru
describ
base
hemagglutin
pattern
red
blood
cell
abil
caus
tumor
rodent
percentag
guanin
plu
cytosin
content
dna
howev
less
half
serotyp
play
role
human
diseas
serotyp
similar
morpholog
nucleic
acid
composit
produc
characterist
cytopath
effect
adenovirus
medium
size
nonenvelop
icosahedron
fiberlik
project
doublestrand
dna
virus
molecular
weight
approxim
fiberlik
project
capsomer
rodlik
structur
knob
function
attach
apparatu
viru
fig
adenoviru
attach
cellular
receptor
name
car
intern
endosom
undergo
process
initi
uncoat
viru
outer
protein
coat
call
capsid
capsid
contain
subunit
refer
transform
interact
epitheli
cell
lytic
interact
pulmonari
epitheli
cell
result
cell
death
inhibit
host
macromolecular
synthesi
transport
cellular
mrna
cytoplasm
lytic
interact
one
million
virion
per
cell
releas
natur
killer
cell
lymphocyt
recognit
infect
cell
elicit
cytokin
respons
induct
cytotox
cell
neutral
nonneutr
antibodi
adenoviru
latent
chronic
infect
adenoviru
involv
lymphoid
cell
adenoviru
sequenc
found
human
lymphocyt
tonsil
small
number
virus
releas
period
time
even
presenc
neutral
antibodi
respons
oncogen
transform
occur
adenovir
dna
integr
replic
host
cell
dna
howev
virion
produc
three
type
interact
epitheli
cell
result
virusspecif
protein
antigen
indic
presenc
adenoviru
definit
diagnosi
adenoviru
infect
made
antigen
detect
polymeras
chain
reaction
pcr
assay
viru
isol
serolog
adenoviru
excret
prolong
period
time
isol
adenoviru
impli
diseas
adenoviru
type
accomplish
hemagglutinationinhibit
neutral
typespecif
antisera
viru
cultur
sputum
nasopharynx
stool
urin
conjunctiv
scrape
monolay
human
epitheli
cell
characterist
cytopath
chang
visual
day
presenc
adenoviru
antigen
detect
sampl
test
immunofluoresc
enzymelink
immunosorb
assay
elisa
serolog
diagnosi
adenoviru
requir
fourfold
rise
antibodi
fix
complement
neutral
viru
prevent
adenovir
hemagglutin
elisa
radioimmunoassay
adenoviru
infect
selflimit
immunocompet
patient
symptomat
treatment
offer
sever
case
among
immunocompromis
patient
cidofovir
ribavirin
vidarabin
human
immun
globulin
alon
combin
administ
variabl
success
howev
overal
efficaci
treatment
agent
establish
thoroughli
studi
viru
first
identifi
guangdong
provinc
china
subsequ
spread
hong
kong
countri
southeast
asia
europ
north
america
eventu
throughout
world
case
death
june
sarscov
genom
quickli
sequenc
found
relat
previous
character
human
anim
coronavirus
electron
microscopi
coronaviru
show
particl
medium
size
nm
pleomorph
outer
envelop
cover
crownlik
surfac
protein
henc
name
coronaviru
fig
famili
coronavirida
two
genera
coronaviru
toroviru
coronavirus
nonseg
posit
sens
singlestrand
methyl
cap
polyadenyl
rna
rna
code
larg
polyprotein
form
sever
nonstructur
structur
protein
cleav
virusencod
proteas
structur
protein
includ
surfac
hemagglutininesteras
protein
surfac
spike
glycoprotein
virion
envelop
respons
receptor
bind
cell
fusion
protein
small
envelop
protein
membran
glycoprotein
respons
bud
envelop
format
nucleocapsid
protein
complex
rna
protein
mediat
attach
sialic
acid
resid
plasma
membran
host
cell
antibodi
protein
neutral
viral
virion
occur
bud
cytoplasm
vesicl
membran
endoplasm
reticulum
particl
transfer
surfac
cell
releas
cell
cell
die
adult
antibodi
coronaviru
two
studi
strain
coronaviru
respiratori
coronavirus
transmit
person
person
occur
mostli
winter
spring
couninfect
two
strain
coronaviru
abl
grow
cultur
cell
coronavirus
abil
undergo
genet
recombin
two
virus
simultan
infect
cell
sens
coronaviru
translat
produc
viral
polymeras
result
fulllength
negativesens
strand
strand
use
templat
produc
mrna
nest
set
transcript
possess
polyaden
end
assembl
tri
temper
climat
viru
respons
upper
respiratori
tract
infect
adult
peak
viral
activ
respiratori
ill
due
coronavirus
may
high
unit
state
strain
commonli
found
caus
larg
epidem
half
individu
infect
respiratori
coronavirus
becom
ill
evidenc
increas
antibodi
titer
reinfect
like
occur
rapid
decreas
antibodi
level
infect
sarscov
caus
sever
acut
atyp
pneumonia
person
clear
histori
exposur
either
sar
patient
set
sarscov
transmiss
occur
ie
china
hong
kong
hanoi
taiwan
singapor
epidemiolog
studi
identifi
numer
case
occur
hospit
involv
health
care
worker
visitor
patient
famili
member
direct
contact
infect
person
sarscov
end
epidem
june
overal
casefat
rate
rang
among
elderli
individu
age
year
person
underli
medic
condit
mortal
rate
high
person
infect
coronaviru
develop
upper
respiratori
tract
ill
cold
symptom
fever
headach
malais
cough
sore
throat
mucopurul
nasal
discharg
chill
enter
infect
neurolog
syndrom
lower
respiratori
tract
involv
ie
pneumonia
pleural
effus
coronaviru
also
describ
mean
durat
symptom
day
rang
day
reinfect
occur
antigen
heterogen
coronavirus
immun
serotyp
specif
elderli
suscept
sever
respiratori
infect
compar
younger
adult
person
infect
sarscov
common
symptom
includ
fever
headach
malais
myalgia
nonproduct
cough
dyspnea
diarrhea
rhinorrhea
sore
throat
commonli
report
symptom
among
patient
sar
patient
especi
patient
year
age
underli
medic
condit
pulmonari
diseas
progress
acut
respiratori
distress
syndrom
ard
estim
mortal
rate
patient
infect
sarscov
often
abnorm
laboratori
valu
lymphopenia
well
elev
creatin
kinas
lactic
dehydrogenas
aspart
aminotransferas
level
respiratori
coronaviru
includ
sarscov
infect
varieti
mammal
bird
number
serotyp
antigen
variat
unknown
coronaviru
isol
grown
cultur
aerosol
respiratori
tract
secret
result
coronaviru
attach
epithelium
nasopharynx
virusreceptor
interact
coronaviru
replic
epitheli
cell
result
cytolyt
effect
ciliat
epitheli
cell
releas
cytokin
chemokin
induc
protein
chemotact
protein
inflammatori
mediat
respons
mani
respiratori
symptom
occur
infect
incub
period
viral
shed
coronaviru
rang
day
incub
period
sarscov
rang
day
viral
shed
report
case
sever
week
pulmonari
histolog
sarscov
infect
describ
presenc
hyalin
membran
format
interstiti
infiltr
lymphocyt
mononuclear
cell
desquam
pneumocyt
alveolar
space
respiratori
coronavirus
isol
clinic
specimen
tracheal
nasopharyng
epithelium
virus
rapidli
detect
antigen
detect
method
util
immunofluoresc
respiratori
cell
enzym
immunoassay
respiratori
secret
revers
transcriptas
pcr
rtpcr
strain
grown
human
diploid
fibroblast
cell
line
sarscov
isol
upper
lower
respiratori
tract
blood
stool
urin
specimen
rtpcr
grown
respiratori
tract
specimen
vero
fetal
rhesu
monkey
kidney
cell
serum
antibodi
sarscov
singl
serum
specimen
fourfold
greater
increas
sarscov
antibodi
titer
acuteand
convalescentphas
serum
specimen
test
use
detect
infect
sarscov
immunoglobulin
igm
detect
case
limit
period
time
igg
detect
first
week
infect
iga
antibodi
probabl
primari
mediat
resist
coronaviru
infect
sinc
infect
initi
nasopharynx
cover
surfac
project
possess
ha
na
activ
fig
extend
lipid
envelop
globular
rodshap
head
involv
attach
viru
neuramin
acidcontain
mucopolysaccharid
receptor
cell
surfac
membran
least
describ
antigen
distinct
least
nine
distinct
na
na
mushroom
shape
function
enzym
catalyz
remov
termin
sialic
acid
sialic
acidcontain
glycoprotein
earli
stage
penetr
viru
integr
membran
protein
includ
protein
present
viral
envelop
protein
treatment
coronavirus
selflimit
support
sarscov
anecdot
report
suggest
steroid
treatment
may
benefit
interferon
shown
vitro
activ
sarscov
ribavirin
sarscov
current
test
variou
antivir
drug
determin
effect
treatment
found
one
first
descript
influenza
viru
outbreak
sydenham
howev
identifi
influenza
attack
rate
report
high
recurr
epidem
febril
respiratori
diseas
due
influenza
viru
occur
everi
year
worldwid
pandem
everi
year
epidem
typic
occur
winter
month
characterist
pattern
outbreak
children
usual
follow
influenzalik
ill
among
adult
follow
increas
hospit
admiss
patient
pneumonia
exacerb
chronic
obstruct
pulmonari
diseas
congest
heart
failur
averag
attack
rate
influenza
epidem
approxim
certain
popul
attack
rate
may
high
rate
infect
highest
among
children
seriou
ill
death
highest
among
person
year
person
underli
medic
condit
influenza
respons
approxim
death
annual
unit
state
pandem
influenza
occur
time
thu
far
greatest
pandem
occur
caus
million
death
worldwid
influenza
virus
belong
famili
orthomyxovirida
classifi
influenza
b
c
base
antigen
structur
genet
epidemiolog
differ
influenza
studi
character
subtyp
base
two
surfac
antigenshemagglutinin
ha
neuraminidas
na
nomenclatur
influenza
strain
includ
influenza
type
place
initi
isol
strain
design
year
isol
influenza
viru
contain
eight
separ
segment
linear
negativesens
singlestrand
rna
ribonucleoprotein
core
arrang
helic
nucleocapsid
surround
lipidcontain
envelop
present
matrix
viru
eight
discret
nucleocapsid
segment
exist
within
envelop
associ
viral
nucleoprotein
three
polymeras
protein
import
target
crossreact
viralspecif
cytotox
lymphocyt
influenza
caus
respiratoryrel
ill
follow
ushap
epidem
curv
attack
rate
greatest
among
young
elderli
lower
antibodi
level
children
commonli
infect
due
crowd
children
schoolroom
aerosol
spread
effici
influenza
epidem
occur
mostli
octob
april
northern
hemispher
may
septemb
southern
hemispher
influenza
pandem
quit
variabl
occur
emerg
new
viru
overal
popul
immun
underli
medic
diseas
cardiovascular
pulmonari
condit
diabet
renal
dysfunct
hemoglobinopathi
immunodefici
risk
factor
sever
influenza
reason
continu
threat
influenza
epidem
pandem
uniqu
abil
viru
alter
antigen
structur
refer
antigen
variat
two
extern
glycoprotein
ha
na
gene
code
ha
na
influenza
rel
unstabl
continu
undergo
mutat
alter
antigen
structur
new
influenza
variant
develop
small
antigen
variat
known
antigen
drift
larg
antigen
variat
known
antigen
shift
antigen
drift
occur
rel
minor
antigen
chang
accumul
point
mutat
viral
replic
occur
major
antigen
site
ha
na
molecul
influenza
viru
undergo
antigen
drift
rapidli
influenza
b
virus
antigen
shift
result
new
viru
popul
immun
major
antigen
shift
lead
pandem
influenza
infect
influenza
viru
occur
inhal
small
particl
aerosol
contain
viru
aerosol
creat
sneez
cough
talk
experiment
condit
nasal
drop
infecti
dose
time
median
tissuecultur
infect
dose
tcid
tcid
aerosol
rout
incub
period
influenza
day
although
viral
multipl
detect
within
hour
viru
shed
respiratori
secret
disappear
day
individu
occur
sever
month
sever
immunocompromis
person
particl
rel
stabl
differ
temperatur
humid
although
surviv
favor
lower
rel
humid
lower
temperatur
histopatholog
individu
typic
uncompl
acut
inflamm
character
diffus
inflamm
hyperemia
edema
mucosa
larynx
trachea
bronchi
vacuol
columnar
cell
desquam
ciliat
columnar
epithelium
basal
layer
cell
individu
cell
may
show
shrinkag
pyknot
nuclei
loss
cilia
viral
antigen
found
epitheli
cell
basal
layer
lymphocyt
histiocyt
also
found
area
epitheli
damag
individu
sever
diseas
histolog
find
includ
extens
necrot
tracheobronch
ulcer
slough
bronchial
mucosa
extens
hemorrhag
hyalin
membran
format
pauciti
polymorphonuclear
cell
infiltr
viral
replic
occur
intracellularli
lead
death
host
cell
decreas
hostcel
protein
synthesi
degrad
blockag
translat
cellular
mrna
degrad
coexpress
protein
apoptosi
cell
death
due
apoptosi
relat
induct
fa
antigen
doublestrand
rna
viral
replic
poison
mitochondria
protein
encod
second
read
frame
gene
incub
period
influenza
viru
hour
influenza
viru
releas
sever
hour
prior
cell
death
infect
nearbi
epitheli
cell
peripher
blood
mononuclear
cell
infect
epitheli
cell
peripher
blood
mononuclear
cell
elicit
releas
cytokin
respons
system
symptom
infect
peripher
blood
mononuclear
cell
polymorphonuclear
leukocyt
lymphocyt
monocyt
result
defect
cell
chemotaxi
phagocytosi
decreas
prolifer
costimul
mononuclear
cell
defect
peripher
blood
mononuclear
cell
relat
viru
replic
direct
toxic
effect
certain
viru
protein
ha
na
nucleoprotein
infect
influenza
viru
elicit
humor
cellmedi
immun
respons
vital
recoveri
infect
cytokin
express
anim
human
studi
found
helper
th
respons
infect
influenza
viru
infect
epitheli
cell
lyse
antibodi
presenc
complement
antibodydepend
cellular
cytotox
cytotox
lymphocyt
cytotox
lymphocyt
peak
day
infect
class
irestrict
cytotox
lymphocyt
associ
reduc
durat
level
influenza
viru
replic
epitheli
cell
infect
influenza
present
differ
complic
first
sign
symptom
influenza
infect
abrupt
onset
fever
dri
cough
uncompl
influenza
infect
character
fever
chill
headach
dri
cough
pharyng
pain
nasal
obstruct
hoars
myalgia
malais
anorexia
ocular
symptom
otiti
media
nausea
vomit
commonli
report
among
children
influenza
ill
influenza
ill
symptom
typic
resolv
sever
day
individu
cough
malais
may
persist
week
primari
influenza
viral
pneumonia
secondari
bacteri
infect
possibl
pulmonari
complic
influenza
infect
primari
influenza
viral
pneumonia
occur
among
suscept
person
underli
cardiovascular
pulmonari
diseas
patient
relentless
progress
classic
influenza
bilater
find
physic
examin
normal
flora
sputum
bacteriolog
secondari
bacteri
pneumonia
occur
among
older
patient
year
underli
pulmonari
cardiac
metabol
diseas
follow
period
improv
within
approxim
week
recrudesc
symptom
fever
sign
symptom
bacteri
pneumonia
secondari
bacteri
infect
like
occur
direct
physic
damag
bronchial
epithelium
impair
normal
ciliari
activ
physic
clearanc
bacteria
lung
gram
stain
cultur
sputum
individu
commonli
reveal
staphylococcu
aureu
streptococcu
pneumonia
haemophilu
influenza
nonpulmonari
complic
also
describ
influenza
myositi
cardiac
complic
myocard
pericard
toxic
shock
syndrom
central
nervou
system
complic
syndrom
transvers
myeliti
encephalopathi
rey
syndrom
resist
reinfect
variabl
degre
protect
within
subtyp
protect
across
subtyp
product
interferon
gener
cytotox
lymphocyt
best
correl
recoveri
acut
influenza
immun
reinfect
reduct
sever
diseas
influenza
virus
mediat
antibodi
serum
respiratori
tract
secret
system
antibodi
respons
igm
igg
iga
influenza
viru
result
develop
antibodi
glycoprotein
ha
na
matrix
nucleoprotein
serum
igg
neutral
antibodi
primari
mediat
resist
influenza
viru
infect
howev
antibodi
one
influenza
viru
type
confer
limit
protect
anoth
influenza
viru
type
peak
antibodi
respons
found
week
infect
antineuraminidas
antibodi
parallel
hemagglutinininhibit
antibodi
hai
primari
method
detect
antigen
related
among
hemagglutinin
influenza
viru
studi
suggest
serum
hai
titer
serum
neutral
titer
associ
protect
infect
antibodi
na
measur
na
inhibit
elisa
antina
antibodi
provid
protect
influenza
infect
reduc
effici
releas
viru
infect
cell
decreas
sever
ill
antibodi
intern
protein
matrix
nucleoprotein
crossreact
protect
infect
immunoglobulin
g
found
nasal
secret
igg
ha
nasal
secret
igg
subtyp
subtyp
found
serum
suggest
nasal
igg
origin
diffus
serum
nasal
haspecif
iga
polymer
iga
subtyp
iga
subtyp
suggest
local
product
deriv
peripher
lymphoid
tissu
memori
cell
deriv
mucosa
cellmedi
respons
import
recoveri
resist
reinfect
influenza
cell
effect
clearanc
influenza
viru
virusspecif
cytotox
lymphocyt
recogn
class
human
leukocyt
antigen
hla
mediat
immun
lysi
infect
cell
express
antivir
cytokin
cell
recogn
epitop
ha
matrix
protein
nucleocapsid
protein
stimul
b
cell
produc
antibodi
ha
na
antivir
sensit
specif
clinic
diagnosi
influenza
influenzalik
ill
compar
viral
cultur
rang
respect
influenza
infect
definit
diagnos
isol
viru
detect
viral
antigen
respiratori
secret
nasal
swab
specimen
throat
swab
specimen
nasal
wash
combin
nose
throat
swab
specimen
incub
viru
onto
rhesu
monkey
kidney
cynomolgu
monkey
kidney
madindarbi
canin
kidney
cell
line
produc
characterist
cytopath
effect
influenza
viru
cultur
embryon
egg
detect
within
day
rapid
detect
viral
antigen
respiratori
secret
perform
enzym
immunoassay
direct
immunofluorescencedirectigen
flu
ab
bectondickenson
cockeysvil
mo
flu
oia
biostar
boulder
co
quickvu
influenza
ab
test
quid
corp
san
diego
ca
zstatflu
zymetx
oklahoma
citi
ok
test
vari
sensit
specif
compar
cell
cultur
test
vari
complex
skill
time
requir
perform
interpret
sensit
appear
improv
nasopharyng
swab
aspir
compar
throat
swab
gargl
nucleic
acid
hybrid
pcr
amplif
use
research
set
offer
higher
sensit
cost
labor
intens
technic
demand
serolog
test
use
complement
fixat
hemagglutin
inhibit
consist
acut
convalesc
sera
avail
make
retrospect
diagnosi
influenza
treatment
person
infect
suscept
influenza
isol
includ
inhibitor
amantadin
rimantadin
neuraminidas
inhibitor
zanamivir
oseltamivir
center
diseas
control
prevent
recommend
person
experienc
potenti
lifethreaten
influenzarel
ill
person
high
risk
seriou
complic
influenza
within
first
day
ill
onset
treat
antivir
medic
inhibitor
amantadin
rimantadin
shown
effect
experiment
induc
natur
occur
influenza
viru
infect
resist
virus
seen
less
unexpos
individu
inhibitor
inhibit
ion
channel
activ
suscept
virus
ion
channel
respons
acidifi
interior
viru
disrupt
interact
matrix
nucleoprotein
allow
ribonucleoprotein
transport
nucleu
replic
occur
common
side
effect
amantadin
central
nervou
system
relat
insomnia
dizzi
difficulti
concentr
neuraminidas
inhibitor
shown
effect
human
experiment
challeng
model
clinic
trialsvirus
reduc
suscept
oseltamivir
isol
adult
pediatr
children
neuraminidas
cleav
termin
sialic
acid
sialic
acidcontain
glycoprotein
serv
host
receptor
attach
influenza
viru
facilit
penetr
viru
secret
respiratori
tract
rich
sialic
acidcontain
macromolecul
neuraminidas
inhibitor
gener
well
toler
common
side
effect
neuraminidas
inhibitor
relat
gastrointestin
symptom
infecti
natur
cold
describ
kruse
volunt
studi
intranas
instil
bacteriafre
filtrat
nasal
secret
cold
suffer
healthi
subject
result
coldlik
symptom
individu
rhinoviru
isol
nasal
secret
cold
suffer
rhinoviru
deriv
greek
root
rhin
mean
nose
sinc
research
isol
character
rhinoviru
develop
highli
sensit
human
embryon
lung
cell
line
classif
system
known
rhinoviru
immunotyp
epidemiolog
studi
demonstr
rhinoviru
caus
common
cold
rhinovirus
estim
caus
adult
cold
occur
mostli
earli
fall
spring
summer
rhinovirus
singlestrand
positivesens
rna
virus
belong
picornavirida
famili
contain
four
structur
protein
exterior
project
interact
neutral
antibodi
structur
protein
nonenvelop
capsid
icosahedr
symmetri
rhinoviru
also
contain
nonstructur
protein
includ
studi
shown
ordinari
indoor
condit
rel
humid
rhinoviru
aerosol
rapidli
inactiv
annual
season
pattern
rhinoviru
infect
peak
fall
smaller
peak
march
april
may
season
pattern
partial
explain
chang
live
condit
rhinovirus
surviv
better
condit
high
rel
humid
studi
rhinoviru
recov
cell
cultur
patient
cold
combin
cultur
pcr
method
infect
rate
rhinoviru
rang
infect
per
personyear
children
year
age
young
adult
transmiss
viru
occur
mostli
home
set
school
daycar
center
schoolag
children
secondari
transmiss
occur
young
sibl
mother
attack
rate
rang
condit
may
lead
increas
suscept
includ
fatigu
emot
stress
poor
nutrit
smoke
live
work
crowd
condit
clinic
manifest
rhinoviru
infect
broadli
classifi
nasal
pharyng
lower
respiratori
involv
includ
wateri
eye
malais
anorexia
rhinorrhea
nasal
obstruct
sore
throat
cough
sneez
hoars
fever
uncommon
incub
period
hour
follow
deposit
viru
nasopharynx
median
durat
symptom
day
week
infect
person
usual
viru
shed
day
document
shed
sever
week
rhinoviru
infect
rate
volunt
challeng
studi
accord
studi
rhinoviru
replic
nasal
passag
detect
nasal
secret
volunt
earli
hour
viral
shed
peak
second
third
day
replic
rhinoviru
occur
ciliat
epitheli
cell
cell
death
result
larg
quantiti
protein
includ
fibrinogen
releas
mucou
membran
nose
histolog
examin
nasal
mucou
membran
reveal
slight
damag
epithelium
damag
elicit
releas
inflammatori
mediat
mediat
bradykinin
lysylbradykinin
prostaglandin
histamin
rant
regul
two
proteas
specif
viral
cleavag
site
rnadepend
rna
polymeras
small
protein
coval
bound
end
viral
rna
design
vpg
capsom
per
nucleocapsid
deep
conserv
hydrophob
cleft
viral
surfac
function
maintain
structur
integr
viral
capsid
facilit
conform
chang
uncoat
viral
rna
end
genom
genomelink
protein
end
polyadenyl
tract
rhinovirus
similar
enterovirus
homolog
genom
distinct
rhinoviru
type
reflect
chronolog
isol
prototyp
strain
serotyp
rhinovirus
suscept
inactiv
acid
ph
higher
densiti
cesium
chlorid
gradient
distinguish
enterovirus
virus
resist
organ
solvent
ether
chloroform
chemic
trichlorofluoroethan
ethanol
weak
phenol
rhinoviru
grow
best
temperatur
temperatur
insid
human
nose
larg
airway
rhinoviru
serotyp
base
receptor
specif
major
group
rhinoviru
util
leukocyt
attach
protein
known
intercellular
adhes
receptor
member
immunoglobulin
superfamili
found
cell
human
origin
includ
hela
cell
fibroblast
cell
respiratori
epithelium
minor
rhinovirus
bind
lowdens
lipoprotein
receptor
worldwid
infect
rhinoviru
occur
earli
childhood
continu
throughout
life
childhood
adolesc
antibodi
level
rhinoviru
rapidli
acquir
peak
young
adulthood
begin
declin
remain
constant
throughout
adulthood
militari
recruit
often
encount
respiratori
diseas
form
rhinoviru
due
close
contact
other
crowd
quarter
allow
exposur
infect
secret
short
distanc
volunt
studi
shown
effect
transmiss
occur
infect
nasal
secret
spread
hand
hand
exposur
fomit
follow
autoinocul
nasal
conjunctiva
mucosa
aerosol
rout
may
also
mean
rhinoviru
transmiss
howev
activ
normal
tcell
express
secret
histamin
increas
blood
flow
infect
cell
caus
swell
congest
increas
mucu
product
serum
neutral
antibodi
igm
iga
igg
produc
nasal
passag
infect
rhinoviru
antibodi
provid
protect
reinfect
serotyp
iga
antibodi
howev
primari
mediat
resist
rhinoviru
rhinoviru
usual
diagnos
clinic
suspicion
rhinoviru
isol
nasal
secret
yield
improv
secret
collect
directli
wash
mucos
surfac
physiolog
salt
solut
definit
diagnosi
rhinoviru
infect
requir
viral
identif
cell
cultur
system
human
embryon
lung
cell
line
strain
mhela
cell
cytopath
effect
usual
occur
within
day
polymeras
chain
reaction
nucleic
acid
probe
increasingli
use
identifi
rhinoviru
serodiagnosi
rhinoviru
infect
done
neutral
test
howev
techniqu
use
routin
basi
due
multipl
rhinoviru
type
treatment
rhinoviru
support
combin
firstgener
antihistamin
nonsteroid
antiinflammatori
drug
support
manag
also
includ
rest
hydrat
decongest
salin
gargl
cough
suppress
support
treatment
may
reliev
symptom
sneez
runni
nose
itchi
eye
congest
current
antivir
therapi
avail
rhinoviru
infect
respiratori
syncyti
viru
rsv
first
describ
morri
colleagu
identifi
chimpanze
coryza
agent
cca
chimpanze
suffer
cold
later
indistinguish
strain
isol
human
respiratori
ill
increas
specif
neutral
antibodi
cca
found
epidemiolog
studi
found
children
antibodi
cca
age
cca
viru
subsequ
renam
respiratori
syncyti
viru
base
clinic
laboratori
manifest
common
caus
lower
respiratori
tract
infect
infant
older
children
adult
common
caus
upper
respiratori
tract
infect
person
experienc
infect
viru
within
first
year
life
evidenc
serolog
children
year
age
yearli
attack
rate
rsv
lower
respiratori
tract
diseas
estim
per
respiratori
syncyti
viru
belong
paramyxovirida
famili
viru
possess
hemagglutinin
neuraminidas
activ
divid
two
major
group
b
antigen
related
two
group
major
differ
two
group
variabl
g
f
sh
protein
major
group
b
found
circul
simultan
outbreak
respiratori
syncyti
viru
envelop
nonseg
singlestrand
negativesens
rna
viru
rna
encod
sever
protein
three
associ
nucleocapsid
five
envelop
three
glycosyl
transmembran
surfac
protein
f
g
sh
nonglycosyl
matrix
protein
two
glycosyl
surfac
protein
f
g
integr
infect
pathogenesi
rsv
f
protein
respons
viral
penetr
fuse
viral
cellular
membran
g
protein
respons
mediat
attach
viru
host
cell
viral
envelop
membran
deriv
plasma
membran
host
cell
transmembran
surfac
sever
glycoprotein
spike
respiratori
syncyti
viru
unstabl
environ
withstand
temperatur
ph
chang
stabl
nonpor
surfac
hour
porou
surfac
less
hour
optim
ph
readili
inactiv
soap
water
disinfect
respiratori
syncyti
viru
found
geograph
area
differ
climat
everi
year
season
outbreak
tend
occur
winter
spring
unit
state
northern
tropic
area
rsv
infect
associ
increas
rainfal
decreas
temperatur
southern
tropic
area
rsv
associ
decreas
rainfal
temperatur
respiratori
syncyti
viru
infect
children
caus
bronchiol
croup
tracheobronch
pneumonia
respiratori
syncyti
viru
rare
found
children
antibodi
specif
rsv
protein
associ
protect
rsv
infect
provid
rational
administr
rsv
hyperimmun
globulin
monoclon
antibodi
infect
person
sever
rsv
diseas
qualit
quantit
antibodi
respons
f
g
protein
rsv
well
defin
appear
correl
resist
reinfect
influenc
presenc
preexist
antibodi
age
host
immunoglobulin
igg
ige
iga
found
nasal
secret
person
infect
rsv
immunoglobulin
appear
earli
rsv
infect
ige
histamin
respons
nasopharynx
secret
associ
wheez
acut
ill
episod
airway
bronchospasm
iga
appear
correl
diminish
titer
viru
cellmedi
immun
import
clearanc
rsv
recoveri
host
immunosuppress
individu
defici
cellular
immun
sever
diseas
prolong
shed
viru
patient
depress
lymphocyt
function
tcell
subset
depress
level
elev
level
cytotox
lymphocyt
ctl
respons
person
infect
rsv
complex
studi
ctl
helper
lymphocyt
respons
correl
cliniwithout
respiratori
diseas
transmit
respiratori
secret
close
contact
infect
person
contamin
object
infect
occur
infecti
materi
contact
mucou
membran
eye
mouth
nose
possibl
inhal
infecti
droplet
risk
factor
rsv
diseas
age
severest
diseas
occur
among
infant
sex
male
affect
femal
socioeconom
factor
crowd
lower
incom
daycar
attend
multipl
sibl
exposur
passiv
smoke
within
month
onset
rsv
infect
immun
rsv
infect
incomplet
variabl
durabl
daycar
studi
children
infect
first
rsv
exposur
becam
infect
reinfect
second
rsv
exposur
becam
infect
reinfect
third
rsv
exposur
transmiss
rsv
occur
inocul
nose
eye
less
effici
mouth
incub
period
day
respiratori
syncyti
viru
infect
confin
respiratori
tractth
upper
respiratori
tract
earli
diseas
lower
respiratori
tract
late
diseas
pathogenesi
rsv
infect
involv
spread
destruct
ciliat
epitheli
cell
respiratori
tract
fig
lymphocyt
peribronchiolar
infiltr
edema
wall
surround
tissu
lead
prolifer
necrosi
bronchiol
epithelium
pulmonari
epithelium
respond
injuri
product
opsonin
collectin
multipl
chemokin
cytokin
rant
macrophag
inflammatori
product
chemokin
cytokin
result
recruit
effector
molecul
neutrophil
macrophag
natur
killer
cell
eosinophil
bronchiol
lumina
becom
obstruct
inflamm
necrot
epithelium
secret
mucu
hyperinfl
result
lumen
narrow
posit
expiratori
pressur
atelectasi
develop
complet
obstruct
absorb
trap
air
bronchiol
result
increas
lung
volum
expiratori
resist
occur
pneumonia
result
interstiti
infiltr
mononuclear
cell
accompani
edema
necrosi
lead
alveolar
fill
although
antibodi
rsv
prevent
viral
replic
nasal
passag
serum
cal
respons
viral
clearanc
respons
rsv
infect
like
result
helper
cell
respons
respons
quantiti
time
specif
type
cell
determin
immunolog
clinic
outcom
rsv
infect
clinic
manifest
rsv
infect
vari
age
presenc
underli
diseas
host
major
clinic
manifest
associ
rsv
infect
includ
bronchiol
pneumonia
croup
otiti
media
apnea
sudden
infant
death
syndrom
infant
children
year
age
infect
rsv
common
caus
lower
respiratori
tract
infect
upper
respiratori
tract
ill
young
children
firsttim
rsv
infect
requir
hospit
major
children
hospit
rsv
infect
month
age
symptom
includ
wheez
rhonchi
rale
rhinorrhea
nasal
congest
cough
lowgrad
fever
dyspnea
hypoxemia
hypoxemia
repres
lower
respiratori
tract
involv
diffus
viral
involv
lung
parenchyma
mean
arteri
oxygen
satur
admiss
one
group
hospit
infant
otiti
media
common
complic
rsv
infect
young
children
infant
preterm
low
birth
weight
g
children
underli
diseas
chronic
lung
diseas
congenit
heart
diseas
immunosuppress
condit
ie
undergo
transplant
bone
marrow
solid
organ
hiv
chronic
diseas
rsv
infect
result
complic
prolong
morbid
mortal
older
children
adult
clinic
manifest
rsv
infect
depend
immun
statu
host
older
popul
infect
rsv
repres
reinfect
healthi
individu
reinfect
rsv
milder
rang
asymptomat
caus
upper
respiratori
tract
ill
nasal
congest
cough
hoars
sore
throat
lowgrad
fever
conjunct
averag
durat
clinic
ill
day
viral
shed
day
person
medic
condit
especi
underli
cardiac
pulmonari
diseas
diseas
may
quit
sever
respiratori
syncyti
viru
caus
cardiovascular
chronic
obstruct
pulmonari
diseas
exacerb
especi
among
individu
institution
diagnosi
rsv
depend
clinic
suspicion
confirm
viral
isol
fig
detect
viral
antigen
viral
rna
serolog
isol
rsv
timeconsum
expens
respiratori
syncyti
viru
isol
nasopharyng
wash
tracheal
secret
nasal
swab
specif
cytopath
chang
usual
seen
within
day
shell
vial
techniqu
hasten
identif
rsv
antigen
detect
test
rapid
less
expens
use
clinic
laboratori
avail
antigen
detect
test
includ
direct
indirect
immunofluoresc
assay
enzym
immunoassay
eia
method
sensit
specif
revers
transcriptas
pcr
consist
higher
sensit
specif
rate
diagnost
tool
use
mainli
research
laboratori
serolog
diagnosi
rsv
usual
done
use
enzym
immunoassay
neutral
assay
serolog
test
rsv
infect
use
epidemiolog
studi
alway
practic
patient
manag
due
delay
acquir
convalesc
sera
also
product
signific
rise
antibodi
titer
alway
occur
especi
young
infant
individu
underli
medic
condit
treatment
patient
mild
diseas
support
includ
adequ
fluid
intak
acetaminophen
reduc
fever
rest
hospit
infant
may
requir
oxygen
therapi
sometim
mechan
ventil
aerosol
ribavirin
bronchodil
agent
corticosteroid
aerosol
cidin
nitric
oxid
extracellular
superoxid
dismutas
poss
microbicid
activ
clara
cell
local
bronchiol
involv
lung
remodel
may
function
nonspecif
immun
lung
host
respons
commun
memori
cell
dendrit
cell
lower
respiratori
tract
humor
cellmedi
host
defens
play
import
role
pulmonari
mucos
immun
like
conduct
airway
surfac
airway
liquid
present
line
alveoli
microbicid
liquid
contain
surfact
fibronectin
immunoglobulin
complement
factor
free
fatti
acid
ironbind
protein
immunolog
point
view
surfact
sever
compon
serv
increas
microbicid
capac
macrophag
affect
freerad
product
lymphocyt
activ
bind
variou
microorgan
includ
virus
bind
microorgan
surfact
may
result
reduc
microbi
virul
enhanc
phagocytosi
neutrophil
alveolar
macrophag
respiratori
tract
made
phagocyt
cell
includ
alveolar
macrophag
interstiti
macrophag
dendrit
cell
intravascular
macrophag
alveolar
macrophag
locat
alveolar
line
fluid
defend
lower
airway
inspir
foreign
materi
alveolar
macrophag
drawn
lung
epitheli
cell
resid
macrophag
produc
chemokin
macrophag
inflammatori
macrophag
chemoattract
alveolar
macrophag
function
phagocytos
elimin
organ
becom
mediat
inflammatori
respons
recruit
neutrophil
product
cytokin
chemokin
interstiti
macrophag
locat
connect
tissu
lung
serv
phagocyt
cell
class
ii
antigen
present
cell
compar
alveolar
macrophag
interstiti
macrophag
demonstr
fcreceptorindepend
phagocytosi
cytokin
product
oxygen
radic
product
dendrit
cell
locat
within
epithelium
trachea
conduct
airway
termin
airway
alveolar
septa
pulmonari
vasculatur
viscer
pleura
also
serv
phagocyt
cell
class
ii
antigen
present
cell
cell
deriv
ribavirin
approv
antivir
therapi
rsv
lower
respiratori
tract
diseas
hospit
infant
studi
shown
broadspectrum
antivir
agent
may
reduc
longterm
pulmonari
sequela
recurr
wheez
result
rapid
improv
clinic
ill
oxygen
bronchodil
corticosteroid
benefit
infant
bronchiol
use
rsvneutral
antibodi
rsvintraven
immunoglobulin
ivig
polyclon
antibodi
intramuscular
monoclon
antibodi
palivizumabhuman
mous
igg
monoclon
antibodi
bind
f
protein
rsv
shown
reduc
risk
hospit
highrisk
children
prematur
without
chronic
lung
diseas
rsvivig
may
also
benefici
treatment
patient
compromis
immun
system
pulmonari
defens
system
includ
anatom
mechan
barrier
respiratori
tract
mucos
immun
barrier
form
first
line
defens
mucos
transmit
pathogen
particl
filter
inhal
air
mouth
nose
small
particl
diamet
travel
lower
respiratori
tract
mechan
barrier
reflex
mechan
cough
sneez
prevent
reduc
amount
inhal
pathogen
respiratori
tract
mucos
defens
system
consist
innat
barrier
mucu
epithelium
innat
immun
mechan
phagocyt
cell
adapt
host
immun
consist
humor
cellmedi
immun
secretori
immunoglobulin
cell
antigenspecif
cytotox
lymphocyt
conduct
airway
made
trachea
bronchi
line
ciliat
columnar
epitheli
cell
secret
antimicrobi
factor
clear
mucu
gener
inflammatori
chemokin
cytokin
attract
inflammatori
phagocyt
cell
lung
three
type
epitheli
cell
type
type
ii
clara
cell
type
cell
alveolar
epitheli
cell
respons
ga
exchang
type
ii
cell
produc
surfac
airway
liquid
contain
lysozym
lactoferrin
secretori
leukocyt
proteinas
inhibitor
cathelifrom
monocyt
migrat
lymphoid
tissu
stimul
tcell
immun
respons
dendrit
cell
also
capabl
product
varieti
chemokin
cytokin
stimul
tcell
bcell
immun
respons
intravascular
macrophag
locat
capillari
endotheli
cell
serv
phagocyt
cell
remov
foreign
damag
materi
enter
lung
bloodstream
recruit
neutrophil
occur
chemokin
cytokin
mediat
vital
inflammatori
respons
lung
complement
factor
specif
fifth
compon
complement
leukotrien
b
peptid
bacteri
cell
wall
also
respons
elicit
mediat
inflamm
recruit
neutrophil
area
inflamm
mediat
respons
attract
maintain
neutrophil
area
lung
injuri
well
regul
inflammatori
process
involv
key
chemokin
cytokin
involv
process
includ
tumor
necrosi
lung
epithelium
produc
antibodi
humor
immun
prevent
bacteri
adher
growth
humor
immun
respiratori
tract
involv
secretori
immunoglobulin
siga
igg
igm
secretori
iga
major
immunoglobulin
involv
humor
immun
respiratori
tract
provid
import
first
line
defens
invas
deeper
tissu
respiratori
tract
virus
prevent
reduc
attach
respiratori
virus
thu
prevent
intern
host
cell
polymer
iga
also
shown
neutral
viru
intracellularli
transport
polymer
iga
piga
across
epitheli
cell
allow
activ
elimin
immun
complex
mucos
site
even
viru
insid
epitheli
cell
mani
live
attenu
viral
vaccin
optim
product
siga
form
mucos
immun
protect
respiratori
tract
virus
secretori
iga
account
total
protein
nasal
secret
provid
antibacteri
antivir
activ
immunoglobulin
igg
igm
also
provid
antibacteri
antivir
activ
aid
bacteri
opson
complement
activ
agglutin
neutral
activ
enter
upper
lower
airway
rout
transud
blood
defici
either
igg
igg
associ
bronchiectasi
progress
dilat
bronchi
bronchiol
consequ
inflamm
cellmedi
immun
respiratori
tract
manifest
cell
cytotox
lymphocyt
especi
import
virus
intracellular
parasit
organ
surviv
within
pulmonari
macrophag
ratio
approxim
estim
lymphocyt
epitheli
surfac
human
lung
cell
cell
outnumb
b
cell
lung
lung
lymphoid
tissu
locat
follicl
along
bronchial
tree
bronchusassoci
lymphoid
tissu
balt
nasalassoci
lymphoid
tissu
nalt
commonli
upper
respiratori
tract
tonsil
adenoid
uncommit
cell
memori
b
cell
exist
differenti
pulmonari
mucos
immun
system
allow
product
specif
immun
effector
promot
remov
elimin
viral
pathogen
challeng
respiratori
mucosa
without
damag
mucos
surfac
impair
ga
exchang
balt
similar
gutassoci
lymphoid
tissu
intestin
tract
intim
involv
pulmonari
mucosa
consid
site
antigen
present
cell
occur
clonal
expans
inhal
antigen
cross
respiratori
epithelia
surfac
encount
antigen
process
cell
b
lymphocyt
balt
stimul
becom
memori
effector
cell
increas
memori
tcell
number
result
local
prolifer
migrat
cell
balt
memori
lymphocyt
locat
submucosa
lamina
propria
lymphocyt
made
mostli
cell
cell
helper
repres
cell
suppressor
pulmonari
lymphocyt
migrat
lymphoid
tissu
lung
parenchyma
effector
cell
locat
epitheli
cell
interstitium
lung
cytotox
lymphocyt
present
pulmonari
mucosa
inhal
antigen
reach
alveolu
encount
antigenpres
cell
activ
alveolar
lymphoid
cell
activ
alveolar
lymphoid
cell
stimul
memori
lymphocyt
migrat
area
inflamm
result
local
accumul
antigenspecif
b
lymphocyt
critic
step
pulmonari
mucosa
colon
invas
viral
pathogen
keep
peopl
healthi
despit
continu
barrag
inhal
pathogen
particul
inflammatori
process
bind
cell
endothelium
via
interact
leukocyt
functionassoci
integrin
lymphocyt
cell
surfac
endothelium
ligand
vascular
cell
adhes
ligand
endothelium
express
via
upregul
inflammatori
mediat
activ
lymphocyt
function
produc
antibodi
cytotox
activ
produc
inflammatori
mediat
cytotox
cell
within
lung
includ
natur
killer
cell
antibodydepend
cytotox
cell
antigenrestrict
cytotox
cell
produc
cytokin
interact
pathogen
unstimul
lymphocyt
produc
memori
lymphocyt
abl
produc
pattern
cytokin
immun
respons
involv
cellmedi
inflammatori
reaction
product
cytokin
immun
respons
involv
humor
immun
cytokin
product
antibodi
product
cytokin
may
secret
immun
respons
granulocytemacrophag
colonystimul
factor
stimul
alveolar
epitheli
cell
express
varieti
integrin
allow
infiltr
retent
lymphocyt
leukocyt
monocyt
respiratori
virus
adenoviru
sarscov
influenzaviru
rhinoviru
respiratori
syncyti
viru
common
caus
pulmonari
nonpulmonari
clinic
syndrom
virus
signific
caus
morbid
mortal
worldwid
pulmonari
defens
difficult
task
balanc
abil
destroy
remov
constant
barrag
foreign
antigen
assault
mucos
tissu
without
caus
undu
injuri
inflamm
pulmonari
mucos
immun
consist
innat
acquir
immun
essenti
protect
host
develop
respiratori
tract
ill
specif
humor
immun
b
cell
immunoglobulin
cellmedi
immun
antigenpres
cell
cell
vital
protect
host
respiratori
virus
protect
mechan
defend
